A robust intensity modulated proton therapy optimizer based on Monte Carlo dose calculation.
Accuracy of dose calculation models and robustness under various uncertainties are key factors influencing the quality of intensity modulated proton therapy (IMPT) plans. To mitigate the effects of uncertainties and to improve the dose calculation accuracy, an all-scenario robust IMPT optimization based on accurate Monte Carlo (MC) dose calculation was developed. In the all-scenario robust IMPT optimization, dose volume histograms (DVHs) were computed for the nominal case and for each uncertainty scenario. All scenarios were weighted by DVH values dynamically throughout optimization iterations. In contrast, probabilistic approach weighted scenarios with fixed scenario weights and worst case optimizations picked one single scenario - the worst scenario for each iteration. Uncertainties in patient setup and proton range were considered in all clinical cases studied. Graphics processing unit (GPU) computation was employed to reduce the computational time in both the MC dose calculation and optimization stages. A previously published adaptive quasi-Newton method for proton optimization was extended to include robustness. To validate the all-scenario algorithm extension, it was compared with the single scenario optimization target volume (OTV) based approach in clinical cases of three different disease sites. Additional comparisons with worst case optimization methods were conducted to evaluate the performance of the all-scenario robust optimization against other robust optimizations. The all-scenario robust IMPT optimization spared organs at risk (OARs) better than the OTV-based method while maintaining target coverage and improving the robustness of targets and OARs. Compared with composite and voxel-wise worst case optimization, the all-scenario robust optimization converged faster, and arrived at solutions of tighter DVH robustness spread, better target coverage and lower OAR dose. An all-scenario robust IMPT treatment planning system was developed using an adaptive quasi-Newton optimization method. The optimization system was GPU-accelerated and based on MC dose calculation. Improved performance was observed in clinical cases when compared with worst case optimization methods.